Branded Generics Market Size to Expand from USD 252.46 Billion in 2023 to USD 410.86 Billion by 2032

 

Branded Generics Market to Reach USD 410.86 Billion by 2032, Growing at 5.60% CAGR: Polaris Market Research

According to a new report by Polaris Market Research, the global branded generic market was valued at USD 265.9 billion in 2024 and is projected to reach USD 410.86 billion by 2032, expanding at a CAGR of 5.60% over the forecast period (2024–2032). Growth is underpinned by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease, the increasing penetration of affordable branded generic drugs, growing government initiatives promoting generic adoption to control healthcare costs, and the steady patent expiry of major branded drugs, which opens the door for lower-cost generic alternatives across key end-use markets. Generics are cheaper than branded drugs that have lost patent protection and remain popular for their affordability and comparable efficacy to their branded counterparts.

What Is Driving Branded Generics Market Growth?

Demand is climbing as the rising prevalence of chronic conditions converges with growing patent expiry of major branded drugs. Manufacturers and healthcare payers are prioritizing affordable generic alternatives, pushing branded generics adoption across retail and hospital pharmacy channels worldwide. Polaris analysts note that government initiatives encouraging generic drug use to reduce healthcare expenditure position the category for sustained growth through 2032, with anti-hypertensive drugs emerging as the largest revenue contributor and hormone-based therapies posting strong incremental gains.

Key Trends Shaping the Branded Generics Industry

Rising ANDA Approvals and New Generic Launches

The FDA approved 93 first generics in 2021, up from 72 in 2020, even as overall ANDA approvals declined from 1,014 in 2019 to 776 in 2021 a trend manufacturers are working to reverse through faster product innovation and pipeline investment.

Complex and Value-Added Generics Gaining Ground

Rising prevalence of metabolic disorders such as thyroid and hormone imbalances is fueling demand for complex generics with modified-release formulations and novel delivery systems, reflecting a shift in the regulatory landscape toward more sophisticated generic drug approvals.

Consolidation Across Pharmacy Distribution Channels

Consolidation among retail pharmacy chains is strengthening their bargaining power with manufacturers, helping lower prescription drug costs for patients while reshaping the competitive landscape and overall market outlook for branded generics.

Market Segmentation: Breaking Down the Branded Generics Market

Polaris segments the branded generics market by drug class, application, distribution channel, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Drug Class

The anti-hypertensive segment accounted for the largest market share in 2022, supported by rising ANDA approvals and generic product launches. The hormones segment is projected to register the strongest growth rate ahead, driven by increasing prevalence of thyroid and sexual hormone imbalances linked to sedentary lifestyles.

By Application

The gastro-intestinal segment held the largest revenue share in 2022, driven by rising prevalence of acid reflux, ulcers, and inflammatory bowel disease. The oncology segment registered steady growth over the study period, fueled by the rising global cancer burden.

By Distribution Channel

The retail pharmacy segment garnered the highest share in 2022, aided by consolidation that has strengthened bargaining power and lowered prescription drug costs. The hospital pharmacy segment recorded robust growth, driven by its central role in dispensing injectable drugs for critical and acute conditions.

Regional Outlook: Where Is Branded Generics Growing Fastest?

North America dominated the branded generics market in 2022 and is expected to maintain its lead, supported by moderately high penetration of branded generic drugs and strong preference among governments and payers seeking lower healthcare costs. Asia Pacific is expected to be the fastest-growing region over the study period, as countries such as India build out manufacturing hubs to address medicine shortages and expand their role as a global supplier of affordable pharmaceuticals.

👉 Get a Free Sample of the Branded Generics Market Report

https://www.polarismarketresearch.com/industry-analysis/branded-generics-market

Competitive Landscape: Leading Branded Generics Companies

Key players profiled in the report include Teva Pharmaceutical, Lupin, Sanofi, and Sun Pharmaceutical Industries, who are focusing on new product approvals, capacity expansion, and licensing agreements to strengthen market position across the anti-hypertensive and gastro-intestinal segments outlined above. Recent moves include the U.S. FDA's October 2025 approval expanding UZEDY (risperidone) extended-release injectable suspension to pediatric schizophrenia patients aged 13 to 17, and Teva's August 2025 FDA approval and launch of the first generic version of Saxenda (liraglutide) for weight management, both aimed at deepening share in high-growth therapeutic areas.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the branded generics market forecast, this report benchmarks market share, segment-level pricing, and forecast data by drug class, application, distribution channel, and region to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking complex generics as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Semiconductor Intellectual Property Market

Philippines Security Operations Center Market

X-Ray Security Screening Market

T4 DNA Ligase Market

Philippines Security Operations Center Market

Muscle Stimulator Market

Air Conditioner Market

Carboprost Tromethamine Market: An Effective Regulator for Excessive Bleeding After Pregnancy

Bus Market

Comments

Post a Comment

Popular posts from this blog

Green Chemistry Meets PVC: Inside the Biobased Materials Boom

  The Growing Momentum Behind Biobased Polyvinyl Chloride For decades, polyvinyl chloride (PVC) has been one of the most widely used plastics on the planet, found in everything from pipes and cables to flooring and packaging. But traditional PVC relies heavily on fossil fuel-based feedstocks, raising concerns about environmental impact and long-term sustainability. Enter bio based polymers a new generation of materials that are transforming how industries think about plastics production. At the center of this shift is the Biobased Polyvinyl Chloride Market , which is expanding rapidly as manufacturers, regulators, and consumers push toward greener alternatives. What Is Driving the Shift Toward Sustainable Plastics? The demand for sustainable plastics isn't just a passing trend it's a structural change in how materials are sourced and manufactured. Rising awareness of plastic pollution, combined with tightening environmental regulations, has pushed industries to rethink...
Read more

How the Centrifugal Fans Market Continues to Lead Industrial Air Movement

  Centrifugal Fans Market: The Workhorse of Heavy-Duty Air Movement When it comes to moving air through demanding industrial environments, few technologies are as dominant as centrifugal fan systems. The centrifugal fans market continues to anchor the broader Industrial Fans Market , which was valued at USD 7.64 billion in 2024 and is projected to grow at a CAGR of 4.5% between 2025 and 2034, reaching an estimated USD 11.84 billion by the end of the forecast period. The centrifugal fans segment held the largest share in 2024, largely due to its ability to move air at high pressure, making it essential for heavy-duty applications that require strong and steady airflow through ducts, filters, and other systems with resistance. Their design allows them to handle dirty air, dust, and other contaminants without damage, making them a natural fit for industries such as mining, cement, and chemical processing. The Fast-Growing Axial Fans Market While centrifugal fans dominate on v...
Read more

Organoids and Spheroids Market Size to Grow from USD 2.14 Billion in 2025 to USD 13.99 Billion by 2034

  Market Overview Polaris Market Research’s latest research report, titled Organoids and Spheroids Market , offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a market defined by constant change and high-stakes decisions, the report serves as a trusted tool for navigating complexities and identifying actionable opportunities. Backed by robust research methodologies and validated data sources, the research report breaks down key market segments, emerging technologies, regulatory shifts, and regional developments that are shaping the market landscape. Along with historical performance and current benchmarks, the study provides forecasts that help businesses anticipate change and adjust strategies accordingly. Whether you're evaluating market entry, product dev...
Read more